APRE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Also see: APRE Shares Outstanding History and APRE YTD Return |
APRE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||
Also see: APRE Shares Outstanding History and APRE YTD Return |
APRE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||
-42.82% CAGR Mouse over chart for data details
|
APRE Stock Price Chart |
About Aprea Therapeutics Inc |
Aprea Therapeutics is a clinical-stage biopharmaceutical company. Co.'s primary synthetic lethality product candidate is ATRN-119, a clinical-stage small molecule inhibitor of ataxia telangiectasia and Rad3-related (ATR), a kinase that plays a critical role in DNA damage response (DDR). Co. is targeting WEE1, a kinase that is a key regulator of multiple phases of the cell cycle. Co.'s primary WEE1 inhibitor product candidate is ATRN-1051. In addition, Co. has a preclinical research program directed at a second-generation ATR inhibitor, ATRN-354. Finally, Co. also has an early preclinical research program, which is aimed at identification of inhibitors of a distinct protein involved in DDR. We show 21 historical shares outstanding datapoints in our APRE shares outstanding history coverage, used to compute APRE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing APRE market cap history over the course of time is important for investors interested in comparing APRE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of APRE versus a peer is one thing; comparing APRE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like APRE can fluctuate over the course of history. With this page we aim to empower investors researching APRE by allowing them to research the APRE market cap history. |
APRE Current Stock Quote |
Free APRE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
APRE Share Performance |
Market Cap Peers |
Aprea Therapeutics (APRE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
APRI Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.